I used to be a bull but have converted to a bear for the following reasons: 1. Authorized still at 1.5b and should also have split by a factor of 300 to 5M. 2. Preferred shares can convert to 667k common so total outstanding should be counted at 3.5M+ 3. Zero shareholder update and no follow up on news announcements. 4. Raise of 4M+ at pre split $0.029 ($9 after split) now worth about $184k could present the risk of shareholder lawsuits. 5. Nasdaq would require another reverse around 1 for 10-20 and would surely again lead to decline in stock price. 6. Cost about double if revenue 7. Printing of stocks and more to come surely. So, $9 is now a pipe dream and back to pennies look far more realistic. It does not help that the CBD market has collapsed and raw material cost dropped 90%. There's nothing to like anymore about this stock and especially management!

Why would they not reduce authorized at the same time by 300? This does not pass the smell test - are they going to issue more shares? Just 2M additional shares will dilute existing shareholders value by 50%, heaven forbid they issue 20+M new shares. Colossal companies manage to get results out within a month, why does it take Canbiola 3 months plus?

Pure Leaf Oil Hemp Oil Extract with Nano Technology Topical Muscle & Joint Salve - 200mg 60mL https://www.amazon.com/dp/B07VRLRT18/ref=cm_sw_r_cp_api_i_alHQDbD5K7A12

To Canbiola Management:
I’ve been holding this stock for a very long time and even accumulated lately but while I see many positives, I feel there’s a need for the company to focus and also bring clarity to some of the PR’s and statements made during the shareholders meeting.
I find it very positive that Revenues are growing tremendously for such a small company and am impressed of money raised in the last two private placements, the latest being about $4M at $0.029.
For clarity maybe you can shed some light in a stockholder memo or other public fashion about a few items:
1. SAM’s units – how many have you purchased and what is the adoption rate and usage utilization on a monthly basis? If you have not kept buying additional units per the company’s commitment announced, then why not?
2. Vending machines, what is the strategy? What is the investment of the ordered machines? What is expected revenues? If to place them in doctors’ offices, then I question why visitors wouldn’t just buy the products from the staff instead.
3. Northwell Hospital, is there an agreement with them or are they considered a regular customer? Where in the hospital are the products sold and which products? Does the hospital also sell competing CBD products or does Canbiola have an exclusive?
4. BOD member, advisors et all: What do they bring to the table in return for stock?
5. Expenses and Profit: Even though revenue has exploded so has expenses, will this continue, or do you see a path to profitability/positive cash flow? If so, when?
6. Seed to Oil: what is the strategy for controlling the entire process? Do you envision buying land and starting from scratch or is the goal to purchase/lease parts/all of existing facilities with production capabilities? How about building relationships with growers who can supply raw material?
7. Lab reports: Will these be updated to more current dates?
8. Any plans for product expansion within CBD and beyond (adding THC for example)?
9. Pure Leaf: Any plans of taking this onto Amazon and similar platforms?
10. Nasdaq: what is the strategy of meeting the requirements, especially min stock price and asset and/or revenue requirements? Expected timeline?
11. Investors relations firm: what are they doing to firm up the base and bring new investors?
12. Anything else that you think will benefit shareholders?
I have not sold and continue holding but getting a clearer picture would benefit my self and surely others.
Thanks

To Canbiola Management:
I’ve been holding this stock for a very long time and even accumulated lately but while I see many positives, I feel there’s a need for the company to focus and also bring clarity to some of the PR’s and statements made during the shareholders meeting.
I find it very positive that Revenues are growing tremendously for such a small company and am impressed of money raised in the last two private placements, the latest being about $4M at $0.029.
For clarity maybe you can shed some light in a stockholder memo or other public fashion about a few items:
1. SAM’s units – how many have you purchased and what is the adoption rate and usage utilization on a monthly basis? If you have not kept buying additional units per the company’s commitment announced, then why not?
2. Vending machines, what is the strategy? What is the investment of the ordered machines? What is expected revenues? If to place them in doctors’ offices, then I question why visitors wouldn’t just buy the products from the staff instead.
3. Northwell Hospital, is there an agreement with them or are they considered a regular customer? Where in the hospital are the products sold and which products? Does the hospital also sell competing CBD products or does Canbiola have an exclusive?
4. BOD member, advisors et all: What do they bring to the table in return for stock?
5. Expenses and Profit: Even though revenue has exploded so has expenses, will this continue, or do you see a path to profitability/positive cash flow? If so, when?
6. Seed to Oil: what is the strategy for controlling the entire process? Do you envision buying land and starting from scratch or is the goal to purchase/lease parts/all of existing facilities with production capabilities? How about building relationships with growers who can supply raw material?
7. Lab reports: Will these be updated to more current dates?
8. Any plans for product expansion within CBD and beyond (adding THC for example)?
9. Pure Leaf: Any plans of taking this onto Amazon and similar platforms?
10. Nasdaq: what is the strategy of meeting the requirements, especially min stock price and asset and/or revenue requirements? Expected timeline?
11. Investors relations firm: what are they doing to firm up the base and bring new investors?
12. Anything else that you think will benefit shareholders?
I have not sold and continue holding but getting a clearer picture would benefit my self and surely others.

I noticed most of the companies presenting have a live webcast but not canbiola. Hopefully not a poorly made video in 2-3 weeks. Guys, this is marketing 101 so please

Looks like Canbiola raised quite a bit of funds in 2019: REG D dated February 2019 for $2M ($1.7M raised at time of filing): https://www.sec.gov/Archives/edgar/data/1509957/000151116419000030/xslFormDX01/primary_doc.xml
REG D dated May 2019 for $4M ($2M raised at time of filing): https://www.sec.gov/Archives/edgar/data/1509957/000149315219008387/xslFormDX01/primary_doc.xml
From 2nd Q PR: “Closed $3,936,700 cash raised subsequent to the end of the quarter” - https://www.globenewswire.com/news-release/2019/08/20/1904224/0/en/Canbiola-Reports-Second-Quarter-2019-Results.html
Looks like both raises was at $0.029

To Canbiola Management:
I’ve been holding this stock for a very long time and even accumulated lately but while I see many positives, I feel there’s a need for the company to focus and also bring clarity to some of the PR’s and statements made during the shareholders meeting.
I find it very positive that Revenues are growing tremendously for such a small company and am impressed of money raised in the last two private placements, the latest being about $4M at $0.029.
For clarity maybe you can shed some light in a stockholder memo or other public fashion about a few items:
1. SAM’s units – how many have you purchased and what is the adoption rate and usage utilization on a monthly basis? If you have not kept buying additional units per the company’s commitment announced, then why not?
2. Vending machines, what is the strategy? What is the investment of the ordered machines? What is expected revenues? If to place them in doctors’ offices, then I question why visitors wouldn’t just buy the products from the staff instead.
3. Northwell Hospital, is there an agreement with them or are they considered a regular customer? Where in the hospital are the products sold and which products? Does the hospital also sell competing CBD products or does Canbiola have an exclusive?
4. BOD member, advisors et all: What do they bring to the table in return for stock?
5. Expenses and Profit: Even though revenue has exploded so has expenses, will this continue, or do you see a path to profitability/positive cash flow? If so, when?
6. Seed to Oil: what is the strategy for controlling the entire process? Do you envision buying land and starting from scratch or is the goal to purchase/lease parts/all of existing facilities with production capabilities? How about building relationships with growers who can supply raw material?
7. Lab reports: Will these be updated to more current dates?
8. Any plans for product expansion within CBD and beyond (adding THC for example)?
9. Pure Leaf: Any plans of taking this onto Amazon and similar platforms?
10. Nasdaq: what is the strategy of meeting the requirements, especially min stock price and asset and/or revenue requirements? Expected timeline?
11. Investors relations firm: what are they doing to firm up the base and bring new investors?
12. Anything else that you think will benefit shareholders?
I have not sold and continue holding but getting a clearer picture would benefit my self and surely others.
Thanks

Amazing potential, wonder if people actually realizes what’s about to happen with this, yet, small CBD company. Not only have we seen tremendous revenue growth from their CBD line of products but the addition of the SAM’s units attacks a whole new market; personal injury usage paid for by no fault insurance. The company says that one unit is expected to bring in $14k/year, 100 units would be $1.4M – that alone is, in my estimation, is more than all revenues for 2018. The commitment calls for 1,650 units in 2018 – 1,650 x $14k = $23M so if they order zero units in 2020 we can expect $23M in Revenue that year. This year should come in around $12M based on their monthly commitments, over 10 times 2018 Revenue (my estimate). That’s GROWTH! And this is only the SAM’s units, not counting CBD product sales. In my humble opinion that 10x growth, everything else being equal, should have the potential to grow the stock price 10x but even 5x (if one assumes dilution from capital raise etc) would give us a stock price of 8 cents x 5 = $0.40.
Last year the company also announced a slew of new manufacturing equipment so I would expect to see an expanded product line as this equipment get online (probably needs certification which takes some time). This new equipment not only increases the output capacity and efficiency in manufacturing but also should have excess capacity to increase private label production.
Lastly, the teams assembled in this company are getting more and more impressive from doctors with vast background and strong reputations to other professionals with government experience (ex-senator) to attorney with personal injury/no fault experience and TEN’s units/pads (Mobius) background.
Nothing is perfect and as the company moves forward I’m sure there will be growth issues, but from my vantage point this winning formula will be hard to mess up. I also see the company as a potential take-over candidate by another, larger, public entity that wants the Revenue (potential) and recognizes what that will do to its own market cap and market coverage.
The above just my opinion, do your due diligence, but I remain VERY bullish and believe the current stock price is extremely cheap when I gaze into my crystal ball

I don’t write much here but seeing some pretty skeptical posts let me make a few points, all just my 2 cents but also the reason I keep buying the stock at these levels:

1. The “old” Wrapmail (WRAP) changed to Canbiola (CANB) less than two years ago – going from a technology company to an alternative health care (CBD) company. Wrapmail was going nowhere fast so they shifted to a sector that looked promising at the time. It looks like a much more promising sector these days now that CBD had become legal in all 50 states, ref latest farm bill.
2. Management has pretty much been the same but the company has added an impressive medical board of advisors, a COO, a CFO and a couple of other advisors with strong backgrounds. Some say this is window dressing but I seriously doubt all of these people would risk their good name and reputation unless they believe in the company, its products and prospects.
3. Marco is a hard nose go-getter who’s got a few bruises along the way (10-20 years ago) but without his stubborn effort this company would most probably not even exist.
4. Revenues from the brand new venture of manufacturing and selling CBD oil, and later Tens units and pads has been steady increasing quarter over quarter. Companies seldom start up a brand new venture without a. investors (yes, that creates dilution but also secures working capital) and b. losing money for a time until they can turn profitable. Anyone who’s started a company (and I have) know that you need money, good strategy, staying power, stubbornness and a good portion of luck (being in the right place at the right time) to succeed.
5. The company went from basically buying products from white label companies to securing their own manufacturing and control the entire value chain – all this in an impressive amount of time. Not possible without risk capital.
6. A lot of people compare Canbiola to CVSI and others as far as potential and I believe this comparison can be sound assuming that management find a way to increase revenues exponentially. You cant justify a 2-,30, 40 million market cap with less than a million revenues but you sure can with $10-20M in revenue. My bet is that they can get there and when they do the stock will not be 6,7,8 cents but probably 25,50 cents or more.
7. Risk is something you take in a startup situation such as Canbiola, the risk is you lose it all or get a windfall in return.
8. Looking at all the pieces that have fallen into place in the past year that’s a risk I am willing to take.

Now we're talking. Having used these products and also sold to my customers for 6 months I must say I am impressed. Delivery and service is great and my total experience makes me comfortable with my investment also in this stock, actually been adding here and will continue as I believe 10 cents is not far off. Looking at volume and float (based on latest filing) I see upwards pressure. Also believe business is growing and will continue to. Who knows, maybe they also start a blockchain. I advise anyone to look at product reviews and also try these products, especially the creams/salves - love those. 2018 could be the year - looking way back this stock was over 70 cents and that was at a time when business is nowhere near the potential it has today (that was back in the wrapmail days with revenues topping out around $100k/year). All just MHO - do your own DD and good luck and happy new year to all!

Now we're talking! Like I've said before, I buy their products and their great (actually looks to me that sales are better than expected as some now have delivery times - out of stock but delivery about a week). Someone gave me a code and using this got me 25% off - you guys should tro - www.canbiola.com and use code: NEXT. I took part in the first round when WRAPmail rtaised money and paid at that time $1/share - took more at a 10 cent round. Firmly believe we can get back above $1. Small float and looks like a lot of it is on the original investor hands (like me) so the actual float is smaller - I would estimate 20M shares as there has been new issues. We need some news and I hope that's fairly soon but I have trust in the products and seeing how my customers love them that's a great testament. Good luck to all, I'm staying long here.

That Facebook post says it all. I looked at this persons background and she's been battling cancer. She says Canbiola combined with some THC product really helped her. I bet such posts converts to orders and that will benefit shareholders!

Got my products and absolutely love them - I would recommend the skin care kit to anyone with allergies who use body and facial products! This is real all around

I just got a notice that products shipped yesterday, ahead of schedule. Can't wait to get them. News of first medical adviser also very positive, maybe they get in to all the Body Works in the US. Comparing this stock with CBDS and it should be over 50 cents so IMHO there's a ton of potential here!

I ordered the skin care products to test and sell from my stores, can't wait. Also noticed a medical advisor added to the about us on the website - impressive credentials. Looks like these guys are putting the right building block together. I also love the name and logo - very unique yet recognizable - up it shall go.

Now it's all about sales and acquisitions. Hopefully some nice deals announced in near future. Would love to also see the products on Amazon. I already see high activity on their Facebook and Twitter pages and that's good. Ps I love the name and logo. Branding branding. Long and strong

I love this transition as the tech solutions seemed to offer little growth. The CBD market is exploding world-wide and is helping a ton of people with various illnesses. I'd not be surprised to see this well into silver VERY shortly.

I hear good things coming through the grapevine. Version 2.0 should be VERY close and hopefully the S1 they announced a while back also happens soon which should give the stock more attention and open up for a new group of investors - audited statements and SEC reporting on QB. I've used WRAPmail for my business almost since inception and have had great results in terms of new leads and new business. Seeing the volume as of late it looks to me that the stock might finally (been a long time) turn the corner and start moving towards new highs. All jmho - do your own DD and at the very least I suggest taking a free trial when new version is out as I believe it will be a lot easier to use, especially making your own wraps! Good luck to all.

DD for WRAP for ALL Investors:
WRAPMAIL has nothing to do with spam emails which per definition is UBE (unsolicited bulk email) or emails from fake senders. The fact that an email between known contacts include images has nothing to do with spam, if it did an old fashioned letterhead through snail mail would be spam per definition. I urge ALL Current and Possible INVESTORS to dig a little further and then come back with input, positive and/or negative…..and we all could have a professional debate on Pros and Cons. What has me buying this stock is the market potential I see and I was even more encouraged learning that they are filing new patent applications and focusing on mobile.

Hi lowhcp and thanks!

To the other guy: plenty of bids at 23 so someone thinks it is worth at least that much. Did you ever test the product or are you just here to make some sort of statement. Ever talk to the company?